Tempus AI reassured investors that its major pharma contracts remain strong despite funding and tariff pressures.
Cathie Wood-Backed Tempus AI Says Pharma Contracts Solid Despite Biotech Funding Challenges, Tariff Pressures
Where Today's News Shapes Tomorrow
